Standout Papers
Citation Impact
Citing Papers
Postoperative Nomogram Predicting Risk of Recurrence After Radical Cystectomy for Bladder Cancer
2006
Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients
2001 Standout
Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma
2005 Standout
Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma
2007 Standout
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
2008 Standout
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
Cardiopulmonary function in two human disorders of the hypoxia‐inducible factor (HIF) pathway: von Hippel‐Lindau disease and HIF‐2α gain‐of‐function mutation
2011 StandoutNobel
Expanding indications for conservative renal surgery in renal cell carcinoma
1994
Guidelines on Urolithiasis<footref rid="foot01"><sup>1</sup></footref>
2001 Standout
Potential therapeutic targets for the treatment of detrusor overactivity
2004
Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study
2006 Standout
The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society
2003 Standout
Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease
2003
The neural control of micturition
2008 Standout
Phaeochromocytoma
2005 Standout
Renal-Cell Carcinoma
1996 Standout
The prevalence of urinary incontinence in women in four European countries
2004
ICIQ: A brief and robust measure for evaluating the symptoms and impact of urinary incontinence
2004 Standout
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Host–pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenicEscherichia colibladder infection
2012
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
The prevalence of nocturia and its effect on health‐related quality of life and sleep in a community sample in the USA
2003
Anticancer activities of histone deacetylase inhibitors
2006 Standout
Innovations and challenges in renal cancer: Summary statement from the Third Cambridge Conference
2009 StandoutNobel
von Hippel-Lindau disease
2003 Standout
Parkinson's disease
2015 Standout
Annual direct cost of urinary incontinence
2001
Histone deacetylases and cancer: causes and therapies
2001 Standout
Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT–PCR: changes in ageing
2005
Bladder cancer
2016 Standout
The Physiological Function of the Urothelium – More than a Simple Barrier
2006
Weight Loss to Treat Urinary Incontinence in Overweight and Obese Women
2009 Standout
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Mutation of von Hippel–Lindau Tumour Suppressor and Human Cardiopulmonary Physiology
2006 StandoutNobel
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
2007 Standout
Urinary Incontinence: Does it Increase Risk for Falls and Fractures?
2000
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
2003 Standout
Urinary Retention, Incontinence, and Dysregulation of Muscarinic Receptors in Male Mice Lacking Mras
2015
Partial nephrectomy for renal cell carcinoma with a normal opposite kidney
1994
Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer
2000
PIEZO2 in sensory neurons and urothelial cells coordinates urination
2020 StandoutNatureNobel
Management of Overactive Bladder
2004
An epidemiological survey of overactive bladder symptoms in Japan
2005
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
2001 Standout
Prevalence of the Overactive Bladder Syndrome by Applying the International Continence Society Definition
2005
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
2015 Standout
Current controversies in nephron-sparing surgery for renal-cell carcinoma
1995
Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress
2011 Standout
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
2001 Standout
Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial
2018
Angiogenesis as a therapeutic target
2005 StandoutNature
Prevalence and burden of overactive bladder in the United States
2003 Standout
Prevalence of Symptomatic Pelvic Floor Disorders in US Women
2008 Standout
Incontinence Severity and Major Depression in Incontinent Women
2005
HIF activation identifies early lesions in VHL kidneys
2002 StandoutNobel
Major classes of sensory neurons to the urinary bladder
2006
Progression and Survival after Renal-Conserving Surgery for Renal Cell Carcinoma: Experience in 104 Patients and Extended Followup
1990
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
2006 Standout
How To Build and Interpret a Nomogram for Cancer Prognosis
2008 Standout
Urothelial ATP signaling: what is its role in bladder sensation?
2016
Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging
2004
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Conservative Surgery for Renal Cell Carcinoma: A Single-Center Experience with 100 Patients
1989
Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.
2000
THE INCIDENCE OF A POSITIVE ICE WATER TEST IN BLADDER OUTLET OBSTRUCTED PATIENTS: EVIDENCE FOR BLADDER NEURAL PLASTICITY
1998
Kidney Preserving Surgery in Renal Cell Tumors: Indications, Techniques and Results in 152 Patients
1993
Are cannabinoids more effective than placebo in decreasing MS-related bladder dysfunction?
2012
Tumor Angiogenesis Correlates with Lymph Node Metastases in Invasive Bladder Cancer
1995
Bladder Cancer
2020 Standout
RENAL CANCER IN FAMILIES WITH HEREDITARY RENAL CANCER: PROSPECTIVE ANALYSIS OF A TUMOR SIZE THRESHOLD FOR RENAL PARENCHYMAL SPARING SURGERY
1999
Tissue-engineered autologous bladders for patients needing cystoplasty
2006 Standout
Is Ipsilateral Adrenalectomy a Necessary Component of Radical Nephrectomy?
1995
The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer
2002 StandoutNobel
The Kock Ileal Neobladder: Updated Experience in 295 Male Patients
1996
Nephron Sparing Surgery in Incidental Versus Suspected Renal Cell Carcinoma
1994
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
2009 Standout
Metabolic Complications of Urinary Intestinal Diversion
1992
Recent developments in the management of detrusor overactivity
2003
Lower Urinary Tract Reconstruction Following Cystectomy In Women Using The Kock Ileal Reservoir With Bilateral Ureteroileal Urethrostomy: Initial Clinical Experience
1994
Radical Cystectomy for Bladder Cancer Today—A Homogeneous Series Without Neoadjuvant Therapy
2003 Standout
Treatment of Renal Cell Carcinoma in Von Hippel-Lindau Disease: A Multicenter Study
1995
Life extension in Drosophila by feeding a drug
2002
The spectrum of nonmotor symptoms in early Parkinson disease
2013
The Control of Prostate-Specific Antigen Expression and Gene Regulation by Pharmacological Agents
2001
Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase.
2001
Cannabinoids for Medical Use
2015 Standout
Partial Nephrectomy for Renal Cell Carcinoma: Indications, Results and Implications
1991
Urinary Bladder Contraction and Relaxation: Physiology and Pathophysiology
2004
SURGERY OF RENAL CELL CARCINOMA
1993
Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma
1999 Standout
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline
2017
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
Combination of phenylbutyrate and 13-cis retinoic acid inhibits prostate tumor growth and angiogenesis.
2001
The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence Society
2002 Standout
Renal Oncocytoma: A Review of Histogenesis, Histopathology, Diagnosis and Treatment
1993
Works of J.W. Thüroff being referenced
Definition of overactive bladder and epidemiology of urinary incontinence
1997
How widespread are the symptoms of an overactive bladder and how are they managed? A population‐based prevalence study
2001 Standout
Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis
2000
Conservative Surgery of Renal Cell Tumors in 140 Patients: 21 Years of Experience
1992
Localization of Segmental Arteries in Renal Surgery by Doppler Sonography
1982
Doppler sonography and B-mode ultrasound scanning in renal stone surgery
1984
Effects of phenylbutyrate on proliferation and apoptosis in human prostate cancer cells in vitro and in vivo.
1999
The International Continence Society "Benign Prostatic Hyperplasia" Study: the botherosomeness of urinary symptoms.
1997
Advanced Bladder Cancer (Stages pT3b, pT4a, pN1 and pN2): Improved Survival after Radical Cystectomy and 3 Adjuvant Cycles of Chemotherapy. Results of a Controlled Prospective Study
1992
Conservative Surgery of Renal Cell Carcinoma
1987
100 Cases of Mainz Pouch: Continuing Experience and Evolution
1988
Conservative Surgery of Renal Cell Carcinoma
1986
The International Continence Society “Benign Prostatic Hyperplasia” Study: The Bothersomeness of Urinary Symptoms
1997
The Mainz Pouch (Mixed Augmentation Ileum and Cecum) for Bladder Augmentation and Continent Diversion
1986
Extended Radical Lymphadenectomy in Patients With Urothelial Bladder Cancer:: Results of a Prospective Multicenter Study
2004
Sacral neuromodulation for treatment of lower urinary tract dysfunction
2000
Lower urinary tract rehabilitation techniques: Seventh report on the standardization of terminology of lower urinary tract function
1992